INCY
NASDAQ · Biotechnology
Incyte Corp
$124.53
-0.11 (-0.09%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+47.97%
YTD
+22.79%
Open$124.09
Previous Close$124.64
Day High$125.55
Day Low$123.03
52W High$132.60
52W Low$81.09
Volume—
Avg Volume1.33M
Market Cap25.87B
P/E Ratio16.04
EPS$7.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$101.74
Above
SMA 200
$86.15
Above
RSI (14)
51.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
35 analysts
Price Target
+66.1% upside
Current
$124.53
$124.53
Target
$206.81
$206.81
$125.25
$206.81 avg
$260.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.29B | 4.60B | 3.83B |
| Net Income | 1.32B | 1.04B | -346,012,622 |
| Profit Margin | 25.0% | 23.8% | -9.0% |
| EBITDA | 1.58B | 1.31B | -409,317,505 |
| Free Cash Flow | — | — | -346,886,835 |
| Rev Growth | +14.8% | +14.8% | -9.6% |
| Debt/Equity | 0.01 | 0.01 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.97 | -0.04% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $405.71 | -0.09% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.81 | -0.37% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $522.63 | +1.22% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $797.37 | -0.56% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $248.51 | +0.81% | 40.0 | 32.33B |